期刊文献+

幼年成骨细胞体外培养传代衰老与70岁以上老年人成骨细胞的生物学特性比较 被引量:2

Comparison of biology characteristics between infant human osteoblasts of subculture senescence and ≥70 year-old human osteoblasts in Vitro
下载PDF
导出
摘要 目的通过对幼年人成骨细胞(osteoblasts,OB)体外培养传代衰老与70岁以上老年人成骨细胞的生物学特性比较,观察培养代数与年龄的相关性,拟建立幼年人成骨细胞体外培养传代模拟衰老模型。方法选取≤5岁(2例,男1,女1)和≥70岁(14例,男5,女9)两个年龄组的股骨颈松质骨进行成骨细胞体外培养,幼年组细胞自第二代开始每5~10d传代一次,至第17代终止。培养期间观察第2,5,10,15代细胞的形态、增殖能力与碱性磷酸酶(alkaline phosphatase,ALP)活性,以及应用RT-PCR方法检测BGP,IGF-1,OPG,ODF基因mRNA表达,并与体外培养的70岁以上老年人成骨细胞进行比较。结果形态观察提示成骨细胞体外连续传代至第10-15代时,其胞体增大、折光性降低,呈塌陷状,细胞器稀少、糖原增多、溶酶体增多,与70岁以上老年人成骨细胞相似。MTT相对比值随传代次数增加而降低,第10-15代细胞明显低于第2-5代细胞,而与70岁以上老年人成骨细胞相似;ALP活性于10-15代时增高,与70岁以上老年人成骨细胞相似。幼年成骨细胞骨钙素(bone gla-protein/osteocalcin,BGP)、胰岛素样生长因子-1(insulin-like growth factor-1,IGF-1)、破骨细胞分化抑制因子(osteoprotegerin,OPG)、破骨细胞分化因子(osteoclast differentiation factor,ODF)、OPG/ODFmRNA表达随传代次数增加呈降低趋势,第10与15代细胞其表达量低于第2代细胞,也低于70岁以上老年人成骨细胞。结论幼年成骨细胞体外连续传代培养10-15代时,其形态结构、增殖能力与某些基因mRNA表达与体外培养第二代70岁以上老年人成骨细胞有相似性,有希望作为体外培养模拟衰老模型。 Purpose To compare the biology characteristics between serially passaged cultures of osteoblasts(OB) of 45 year-old donors and osteoblasts of ≥70 year-old donors, in order to establish the model of osteoblastic senescence in vitro. Methods Human osteoblasts from different age donors (2 aged 45 years, male 1, female 1 ; 14 aged≥70 years, male 5, female 9) were isolated and cultured in vitro. The osteoblasts of infant donors were serially subcultured every 5 - 10 days until to 17 th passage. The cell morphology, proliferation, ALP activity and mRNA expressions of BGP, IGF-1, OPG, ODF of the 2 nd, 5 th, 10 th and 15 th subcultures were compared with that of osteoblasts of ≥70 year-old donors. Results Morphology observation showed that the osteoblasts were larger, collapselike, with feeble refraction, few organelles, accumulated glycogen and more lysosomes in plasma when subcultured serially to 10 th- 15 th passage, being similar to osteoblasts of ≥70 year-old donors. MTT relative ratio was decreased with increasing subcultures. MTT relative ratio was much lower in 10 th- 15 th passage cells of infant donors than in 2 nd - 5 th passage cells, being similar to osteo-blasts of ≥70 year-old donors. ALP activity was higher in 10 th- 15 th osteoblasts, which was similar to osteoblasts of ≥70 year-old donors, mRNA expressions of BGP, IGF-1, OPG, ODF, OPG/ODF were decreased with increasing subcultures, and was lower in 10 th- 15 th passage cells of infant donors than in 2 nd passage cells, being also lower than in osteoblasts of ≥70 year-old donors too. Conclusions The 10 th- 15 th passage osteoblasts from infant donors are similar to the 2nd passage osteoblasts from ≥70 year-old donors in morphology characteristics, proliferation and some genes mRNA expression, which may be used as the aging model in vitro.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2007年第1期42-46,56,共6页 Fudan University Journal of Medical Sciences
基金 国家自然科学基金项目(39970809)
关键词 人成骨细胞 传代衰老 生物学特性 基因表达 human osteoblasts subculture senescence biology characteristics gene expressions
  • 相关文献

参考文献11

  • 1Raisz LG.Pathogenesis of osteoporosis:concepts,conflicts,and prospects[J].J Clin Invest,2005,115(12):3318
  • 2Chen TL.Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment[J].Bone,2004,35(1):83
  • 3Peterson WJ,Tachiki KH,Yamaguchi DT.Serial passage of MC3T3-E1 cells down-regulates proliferation during osteogenesis in vitro[J].Cell Prolif,2004,37(5):325
  • 4于明香,金慰芳,顾淑珠,王洪复.体外培养人成骨细胞随供体的增龄而改变[J].中华内分泌代谢杂志,2002,18(2):116-119. 被引量:9
  • 5于明香,金慰芳,顾淑珠,王洪复.体外培养人成骨细胞BGP、IGF-1基因表达的增龄改变[J].复旦学报(医学版),2002,29(2):105-108. 被引量:8
  • 6于明香,王洪复,金慰芳,顾淑珠.体外培养人成骨细胞OPG、ODF基因表达与增龄相关[J].中华内分泌代谢杂志,2004,20(3):270-271. 被引量:7
  • 7Stanley JF,Pye D,MacGregor A.Comparison of doubling numbers attained by cultured animal cells with life span of species[J].Nature,1975,255(5504):158
  • 8Hayflick L.The cell biology of aging[J].Clin Geriatr Med,1985,1(1):15
  • 9Kassem M,Ankersen L,Eriksen EF,et al.Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts[J].Osteoporos Int,1997,7(6):514
  • 10Huang W,Carlsen B,Rudkin GH,et al.Effect of serial passage on gene expression in MC3T3-E1 preosteoblastic cells:a microarray study[J].Biochem Biophys Res Commun,2001,281(5):1120

二级参考文献12

  • 1朱文菁,金慰芳,张丽丽,张罗修,王洪复.MTT法分析培养成骨细胞的存活和增殖能力[J].上海医科大学学报,1995,22(4):254-257. 被引量:79
  • 2Udagawa N. Mechanisms involved in bone resorption. Biogerontology, 2002;3:79-83.
  • 3Makhluf HA, Mueller SM, Mizuno S, et al. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. Biochem Biophys Res Commun, 2000,268:669-672.
  • 4Shigeyama Y, Pap T, Kunzler P, et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum, 2000,43:2523-2530.
  • 5Kuliwaba J S, Findlay DM, Atkins GJ, et al. Enhanced expression of os teocalcinmRNA in human osteoarthritic trabecular bone of the proximal femur is associated withdecreased expression of interleukin-6 and inter leukin-11 mRNA. J bone Miner Res,2000,15:332
  • 6Swolin D, Brantsing C,Matejka G, et al. Cortisol decreases IGF-1 mRNA levds inhuman osteoblast-like cells. J Endocrinol, 1996,149: 397
  • 7KveiborgM,RattanSI,ClarkBF,et al.Treatment with 1,25-dihydroxyvitamin D3 reducesimpairment of human osteoblast functions during cellular aging in culture. J Cell Ph ysiol, 2001,186 : 298
  • 8Martinez ME, del Campo MT, Medirna S, et al. Influence of skeletal site of originand donor age on osteoblastic cell growth and differentiation.Calci f Tissue Int,1999,64:280
  • 9Kveiborg M, Flyvbjerg A, Ratttan SI, et al. Changes in the insulin-like growthfactor-system may contribute to in vitro age-related impaired osteoblast functions. ExpGerontol,2000,35:1061
  • 10Aubin JE. Advances in theosteoblast lineage. Biochem Cell Biol, 1998,76: 899

共引文献19

同被引文献9

  • 1王前,钟世镇,龚文汇,欧阳钧.鼠颅盖骨成骨细胞体外培养及ALP免疫组化法鉴别纯化[J].中华骨科杂志,1995,15(6):364-366. 被引量:32
  • 2王卫华.成骨细胞体外培养方法研究进展[J].国外医学(口腔医学分册),1996,23(5):287-291. 被引量:16
  • 3Seeman E. Invited Review: Pathogenesis of osteoporosis[J] . J Appl Physiol, 2003, 95(5): 2142 -2151.
  • 4Seeman E, Eisman JA. Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual' s absolute risk of fracture [ J]. Med J Aust, 2004, 180 (6) : 298.
  • 5EMEA. Guideline on the Evalution of New Medicinal Products in the Teatment of Primary Osteoporosis[EB/OL]. http: //www. emea. europa. eu/pdfs/human /ewp/055295en. pdf, 2008.
  • 6FDA. Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis[EB/OL]. http: //www. fda. gov/cder/guidance / osteo, pdf, 2008.
  • 7JANEBLIAN, GARY SSTEIN. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation [J]. Oral Biology and Medicine, 1992, 3 (3):269-305.
  • 8章静波,徐存拴.动物细胞培养-基本技术指南[M].第4版.北京:科学出版社,2004:447-449.
  • 9高建军,顾淑珠,周轶,金慰芳,王洪复.大鼠破骨细胞数量和功能的增龄性变化[J].中华老年医学杂志,2004,23(3):184-187. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部